Zobrazeno 1 - 10
of 33
pro vyhledávání: '"Yasuhiro Hisanaga"'
Autor:
Yasuhiro Hisanaga, Shusuke Kitabatake, Hidenori Toyoda, Satoshi Yasuda, Makoto Tanikawa, Akira Kanamori, Shohei Shiota, Takashi Kumada, Yoshio Sumida, Seiki Kiriyama, Takahiro Koyabu, Daiju Furukawa, Manabu Furoi, Satoshi Yamamoto
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::25e583826f84764bd3ae50f7d1728300
https://doi.org/10.1002/ygh2.418/v2/response1
https://doi.org/10.1002/ygh2.418/v2/response1
Autor:
Shusuke Kitabatake, Seiki Kiriyama, Yasuhiro Hisanaga, Junko Tanaka, Akira Kanamori, Makoto Tanikawa, Takashi Kumada, Tsuyoki Yama, Toshifumi Tada, Hidenori Toyoda
Publikováno v:
Journal of Gastroenterology and Hepatology. 32:687-694
Background and Aim Eradication of hepatitis C virus (HCV) with interferon (IFN)-based therapy has been reported to reduce all-cause mortality in patients with chronic HCV infection. However, the impact of HCV eradication on non–liver-related mortal
Autor:
Shusuke Kitabatake, Yasuhiro Hisanaga, Junko Tanaka, Makoto Tanikawa, Seiki Kiriyama, Akira Kanamori, Hidenori Toyoda, Takashi Kumada, Tsuyoki Yama, Toshifumi Tada
Publikováno v:
Hepatology Research. 47:1021-1031
Aim The rate of hepatocellular carcinoma (HCC) development is reportedly lower in patients with chronic hepatitis C virus (HCV) who have achieved a sustained virological response (SVR) than in patients who were unresponsive to therapy. However, the d
Autor:
Yasuhiro Hisanaga, Toshifumi Tada, Shusuke Kitabatake, Akira Kanamori, Takashi Kumada, Tsuyoki Yama, Makoto Tanikawa, Seiki Kiriyama, Hidenori Toyoda
Publikováno v:
Journal of Gastroenterology and Hepatology. 30:1412-1419
Background and Aim It has been reported that the branched-chain amino acid (BCAA) to tyrosine ratio (BTR) is a useful indicator of liver function and BCAA therapy is associated with a decreased incidence of hepatocellular carcinoma (HCC). However, th
Autor:
Takanori Ito, Shusuke Kitabatake, Takashi Kumada, Toshifumi Tada, Yasuhiro Hisanaga, Makoto Tanikawa, Seiki Kiriyama, Akira Kanamori, Hidenori Toyoda
Publikováno v:
Journal of Viral Hepatitis. 22:777-783
The FIB-4 index is a simple formula using age, aspartate aminotransferase, alanine aminotransferase (ALT) and platelet count to evaluate liver fibrosis. We investigated the ability of the FIB-4 index for hepatocarcinogenesis in hepatitis C virus (HCV
Autor:
Shinji Satomura, Makoto Tanikawa, Takashi Kumada, Junko Tanaka, Chiaki Kagebayashi, Hidenori Toyoda, Seiki Kiriyama, Akira Kanamori, Toshifumi Tada, Yasuhiro Hisanaga
Publikováno v:
Journal of Gastroenterology
Background Prognosis of patients with hepatocellular carcinoma (HCC) remains poor because HCC is frequently diagnosed late. Therefore, regular surveillance has been recommended to detect HCC at the early stage when curative treatments can be applied.
Autor:
Toshifumi Tada, Yusuke Ando, Makoto Tanikawa, Kenta Yamamoto, Seiki Kiriyama, Takashi Kumada, Hidenori Toyoda, Ryohei Hasegawa, Shusuke Kitabatake, Akira Kanamori, Tatsuya Tanaka, Yasuhiro Hisanaga, Takuro Niinomi, Takanori Ito
Publikováno v:
Hepatology Research. 44:288-295
Aim It has been reported that branched-chain amino acids (BCAA) supplementation can improve nutritional status and reduce liver-related complications in patients with decompensated cirrhosis. BCAA supplementation reportedly reduces the incidence of h
Autor:
Hidenori Toyoda, Junko Tanaka, Toshifumi Tada, Makoto Tanikawa, Akira Kanamori, Takashi Kumada, Seiki Kiriyama, Yasuhiro Hisanaga
Publikováno v:
Journal of Gastroenterology and Hepatology. 28:357-364
Background and Aim The average age of hepatitis C virus (HCV)-related hepatocellular carcinoma (HCC) patients has been rising in Japan. We evaluate characteristics of HCV-positive patients who develop HCC in older age to determine an optimal surveill
Autor:
Seiki Kiriyama, Takashi Kumada, Junko Tanaka, Toshifumi Tada, Akira Kanamori, Makoto Tanikawa, Tsuyoki Yama, Shusuke Kitabatake, Hidenori Toyoda, Yasuhiro Hisanaga
Publikováno v:
Journal of hepatology. 65(1)
Background & Aims Several hepatitis B virus (HBV) markers have been identified as factors associated with the development of hepatocellular carcinoma (HCC) in patients with chronic hepatitis B (CHB). We clarified the predictive power of HBV markers f
Autor:
Takashi Kumada, Junko Tanaka, Toshifumi Tada, Seiki Kiriyama, Tsuyoki Yama, Akira Kanamori, Shusuke Kitabatake, Makoto Tanikawa, Yasuhiro Hisanaga, Hidenori Toyoda
Publikováno v:
Liver international : official journal of the International Association for the Study of the Liver. 36(6)
Background & Aims Eradication of hepatitis C virus (HCV) by interferon (IFN)-based therapy has been reported to reduce all-cause mortality rates in patients with chronic HCV infection. However, the impact of HCV eradication on non–liver-related mor